Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.49%2.58B | 1.41%1.68B | 2.90%828.2M | -14.08%3.4B | -16.37%2.54B | -22.46%1.66B | -22.65%804.88M | -13.39%3.96B | -9.67%3.04B | -5.35%2.14B |
| Operating revenue | 1.49%2.58B | 1.41%1.68B | 2.90%828.2M | -14.08%3.4B | -16.37%2.54B | -22.46%1.66B | -22.65%804.88M | -13.39%3.96B | -9.67%3.04B | -5.35%2.14B |
| Other operating revenue | ---- | 0.28%47.46M | ---- | 79.38%97.51M | ---- | 147.70%47.32M | ---- | 97.73%54.36M | ---- | 44.35%19.11M |
| Total operating cost | -5.90%1.83B | -8.20%1.19B | -7.58%590.89M | -18.16%2.61B | -19.95%1.94B | -25.03%1.29B | -23.57%639.33M | -14.27%3.19B | -9.56%2.43B | -3.15%1.73B |
| Operating cost | -4.44%1.33B | -7.57%849.85M | -6.39%420.65M | -23.74%1.85B | -26.17%1.39B | -32.97%919.44M | -32.18%449.36M | -18.86%2.43B | -13.12%1.88B | -5.26%1.37B |
| Operating tax surcharges | 7.20%56.87M | 10.44%38.2M | 9.74%18.87M | 9.03%71.45M | 9.00%53.05M | 9.79%34.59M | 6.92%17.19M | 10.62%65.53M | 11.35%48.67M | 17.56%31.5M |
| Operating expense | -15.17%795.43K | -12.31%560.85K | -13.31%294.16K | -5.62%1.32M | -10.46%937.71K | -9.55%639.59K | 54.45%339.34K | 46.89%1.39M | 68.17%1.05M | 107.99%707.15K |
| Administration expense | 1.75%155.45M | 4.99%105.22M | 5.80%53.15M | 7.88%232.86M | 7.12%152.77M | 10.56%100.22M | 18.86%50.23M | 9.63%215.86M | 11.90%142.62M | 9.99%90.65M |
| Financial expense | -17.22%285.32M | -19.05%191.2M | -20.02%96.73M | -5.37%447.55M | -1.88%344.68M | 3.45%236.21M | 5.86%120.96M | 1.99%472.95M | 2.30%351.29M | 3.77%228.32M |
| -Interest expense (Financial expense) | -17.49%287.59M | -19.03%193.14M | -20.05%97.76M | -6.50%453.4M | -3.34%348.55M | 1.54%238.55M | 4.09%122.29M | -2.16%484.91M | -3.12%360.61M | -5.07%234.93M |
| -Interest Income (Financial expense) | 41.04%-3.88M | 35.60%-2.91M | 31.43%-1.51M | 36.76%-8.6M | 37.97%-6.58M | 36.90%-4.52M | 36.91%-2.2M | -2.56%-13.6M | -7.24%-10.61M | -7.44%-7.17M |
| Research and development | -1.88%3.64M | -0.24%2.46M | -4.05%1.2M | -3.73%7.1M | -6.43%3.71M | -2.08%2.47M | 12.54%1.25M | -15.29%7.37M | -25.03%3.97M | -37.27%2.52M |
| Credit Impairment Loss | -76.84%-33.4M | -227.53%-46.87M | -712.31%-24.79M | -27.75%-45.17M | 8.10%-18.89M | -10.16%-14.31M | 47.43%-3.05M | -368.51%-35.36M | -15.23%-20.55M | -1.42%-12.99M |
| Asset Impairment Loss | -874.06%-2.64M | -750.61%-2.79M | -414.92%-693.29K | -354.02%-126.5M | 110.48%341.05K | 116.05%429.49K | 119.18%220.15K | -3.50%-27.86M | 79.40%-3.25M | 78.18%-2.68M |
| Other net revenue | -7.40%43.76M | -101.86%-428.97K | -85.26%2.25M | -695.65%-79.88M | 56.70%47.26M | 27.02%23.07M | 71.48%15.23M | -73.01%13.41M | 288.68%30.16M | 948.89%18.16M |
| Asset deal income | -15,850.76%-119.11K | -116.45%-53.01 | -99.94%9 | -99.86%5.94K | -73.98%756.21 | -72.13%322.2 | 1,199.21%15.02K | 164.20%4.35M | 100.04%2.91K | 100.02%1.16K |
| Other revenue | 21.45%79.92M | 33.24%49.24M | 53.64%27.73M | 26.99%91.79M | 21.94%65.8M | 9.23%36.95M | 13.98%18.05M | 17.84%72.28M | 37.48%53.96M | 62.73%33.83M |
| Operating profit | 23.00%797.22M | 27.16%495.94M | 32.52%239.56M | -9.05%704M | 0.52%648.16M | -10.19%390.01M | -15.12%180.78M | -13.04%774.05M | -6.71%644.83M | -9.33%434.25M |
| Add:Non operating Income | -32.54%1.18M | -34.14%808.8K | -30.89%307.12K | -30.28%2.67M | -10.71%1.75M | 10.10%1.23M | -19.46%444.42K | 46.85%3.82M | -4.08%1.96M | -23.28%1.12M |
| Less:Non operating expense | 82.21%699.1K | 132.41%424.77K | 639.35%272.31K | -33.73%522.52K | -42.04%383.69K | -33.64%182.77K | -81.56%36.83K | -28.64%788.42K | -21.87%661.95K | -10.69%275.44K |
| Total profit | 22.81%797.7M | 26.92%496.33M | 32.24%239.6M | -9.13%706.14M | 0.53%649.52M | -10.12%391.06M | -15.07%181.19M | -12.85%777.09M | -6.69%646.12M | -9.37%435.09M |
| Less:Income tax cost | 28.45%149.65M | 45.19%97.75M | 28.96%44.17M | -7.23%105.4M | 39.66%116.5M | 22.42%67.33M | -1.33%34.25M | 6.00%113.61M | 10.26%83.42M | 24.45%54.99M |
| Net profit | 21.58%648.05M | 23.12%398.58M | 33.00%195.43M | -9.45%600.74M | -5.27%533.02M | -14.83%323.73M | -17.74%146.94M | -15.42%663.47M | -8.76%562.7M | -12.80%380.1M |
| Net profit from continuing operation | 21.58%648.05M | 23.12%398.58M | 33.00%195.43M | -9.45%600.74M | -5.27%533.02M | -14.83%323.73M | -17.74%146.94M | -15.42%663.47M | -8.76%562.7M | -12.80%380.1M |
| Less:Minority Profit | -26.57%21.57M | 3.08%21.34M | 29.45%10.46M | -54.19%15.66M | 9.59%29.38M | 29.12%20.71M | 0.63%8.08M | -13.86%34.19M | 2.59%26.81M | -17.16%16.04M |
| Net profit of parent company owners | 24.39%626.48M | 24.49%377.23M | 33.21%184.96M | -7.02%585.08M | -6.02%503.64M | -16.76%303.03M | -18.60%138.85M | -15.51%629.28M | -9.27%535.89M | -12.60%364.06M |
| Earning per share | ||||||||||
| Basic earning per share | 25.00%0.45 | 22.73%0.27 | 30.00%0.13 | -6.67%0.42 | -5.26%0.36 | -15.38%0.22 | -16.67%0.1 | -15.09%0.45 | -9.52%0.38 | -13.33%0.26 |
| Diluted earning per share | 20.00%0.42 | 23.81%0.26 | 30.00%0.13 | -4.65%0.41 | -2.78%0.35 | -12.50%0.21 | -9.09%0.1 | -10.42%0.43 | -5.26%0.36 | -11.11%0.24 |
| Other composite income | ||||||||||
| Total composite income | 21.58%648.05M | 23.12%398.58M | 33.00%195.43M | -9.45%600.74M | -5.27%533.02M | -14.83%323.73M | -17.74%146.94M | -12.93%663.47M | -5.31%562.7M | -8.06%380.1M |
| Total composite income of parent company owners | 24.39%626.48M | 24.49%377.23M | 33.21%184.96M | -7.02%585.08M | -6.02%503.64M | -16.76%303.03M | -18.60%138.85M | -12.88%629.28M | -5.68%535.89M | -7.61%364.06M |
| Total composite income of minority owners | -26.57%21.57M | 3.08%21.34M | 29.45%10.46M | -54.19%15.66M | 9.59%29.38M | 29.12%20.71M | 0.63%8.08M | -13.86%34.19M | 2.59%26.81M | -17.16%16.04M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.